Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app help beat opioid addiction?

NCT ID NCT06134882

Disease control Sponsor: Western Michigan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Aug 26, 2026 · Updated 4 times

Summary

This study tests whether a smartphone app can help people with opioid use disorder stay drug-free. Participants use the app to submit video-recorded saliva drug tests, earn rewards for staying abstinent, complete therapy modules, and get support from a peer. The study involves 250 adults in the U.S. and lasts one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Smartphone app with contingency management, cognitive-behavior therapy modules, and peer support
What this could lead to
If successful, this could provide an accessible, low-cost tool to help people with opioid use disorder maintain abstinence and engage in treatment.
What could go wrong
This is a behavioral intervention study, not a drug trial. Results may vary widely, and the app's effectiveness depends on participant engagement and adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

97 people

The number who actually took part.

Started

Apr 2024

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 or older * Lives in the United States * Read and speak English fluently * Owns a smartphone compatible with the DynamiCare app (e.g., Apple or Android) * Diagnosed with opioid use disorder or attests to having problem opioid use * Has used unprescribed opioids within the prior 30 days * Has, or is willing to accept, an appointment to initiate medication assisted treatment or has initiated medication assisted treatment in the prior 45 days * Must have an ASAM CO-Triage score between L1 and L3.1 Exclusion Criteria: * Is currently enrolled in another study involving substance abuse treatment * Has concurrent alcohol use disorder * Is currently incarcerated * Has current suicidal ideation or overt psychosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Drug abuse are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Drug abuse Opioid-related disorders

Contacts and locations

Locations

  • Western Michigan University

    Kalamazoo, Michigan, 49008, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.